Takeda Of Japan, U.S.-Based Janssen To Market Alzheimer's Drug
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical and Janssen Pharmaceutical KK have signed a pact to share Japan marketing efforts for a drug to treat Alzheimer's disease